| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.4M | +887.1% |
| Cost of Revenue | $1.2M | +415.9% |
| Gross Profit | $2.3M | +1763.9% |
| R&D Expense | $743K | +188.0% |
| SG&A Expense | $6.5M | +44.7% |
| Operating Income | -$5.0M | -7.4% |
| Net Income | -$11.8M | -154.1% |
| EPS (Basic) | -$178.33 | — |
| EPS (Diluted) | -$178.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.7M | +43.3% |
| Accounts Receivable | $115K | +117.0% |
| Inventory | $913K | +268.1% |
| Current Assets | $9.0M | +53.4% |
| Total Assets | $9.8M | +52.7% |
| Current Liabilities | $14.9M | +3041.3% |
| Total Liabilities | $15.0M | +2375.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | +2.3% |
| Capital Expenditures | $502K | +73.7% |
| Investing Cash Flow | -$502K | -73.7% |
| Financing Cash Flow | $7.7M | -26.3% |
| Free Cash Flow | -$5.4M | -1.8% |
| — |
| Stockholders' Equity |
| -$5.2M |
| -189.6% |